Metagenomi (MGX) Operating Income (2023 - 2025)
Historic Operating Income for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to -$22.8 million.
- Metagenomi's Operating Income fell 203.73% to -$22.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$92.3 million, marking a year-over-year decrease of 428.94%. This contributed to the annual value of -$88.9 million for FY2024, which is 1326.12% down from last year.
- Per Metagenomi's latest filing, its Operating Income stood at -$22.8 million for Q3 2025, which was down 203.73% from -$21.0 million recorded in Q2 2025.
- Metagenomi's 5-year Operating Income high stood at -$16.9 million for Q2 2024, and its period low was -$29.0 million during Q1 2024.
- For the 3-year period, Metagenomi's Operating Income averaged around -$21.7 million, with its median value being -$21.0 million (2025).
- Data for Metagenomi's Operating Income shows a peak YoY increase of 612.37% (in 2024) and a maximum YoY decrease of 6184.64% (in 2024) over the last 5 years.
- Quarter analysis of 3 years shows Metagenomi's Operating Income stood at -$20.2 million in 2023, then fell by 2.11% to -$20.6 million in 2024, then dropped by 10.75% to -$22.8 million in 2025.
- Its Operating Income stands at -$22.8 million for Q3 2025, versus -$21.0 million for Q2 2025 and -$27.8 million for Q1 2025.